
Contact Us
Looking for support along your commercialization journey? We'll help you make sense of your data.
At KMK we focus on results, not just ideas. We work together with our clients to develop solutions that work in the real world.
Make smarter business decisions with our enterprise-level data enrichment solution tools and applications.
Best thinking and results to guide you
At KMK we focus on results, not just ideas. We work together with our clients to develop solutions that work in the real world.
Make smarter business decisions with our enterprise-level data enrichment solution tools and applications.
Best thinking and results to guide you
Getting it right every time is what makes us stand out.
Why KMK?
Careers
Newsroom
Leadership
View All Events
Life @ KMK US
Life @ KMK India
Get a detailed vision of our HEOR, Real World Data & Real-World Evidence solutions and offerings.
KMK’s Latest Case Studies
Sorry, we couldn't find any posts. Please try a different search.
KMK’s Latest
Sorry, we couldn't find any posts. Please try a different search.
Neurology: Clinical Practice
Unmet Need in the Market Economic Burden Increased with Number of Treatment Failures in Migraine Patients – A Retrospective Claims Database Analysis in the United States
KMK Participants : Lujia Zhou
Springer-Drugs-Real World Outcomes
Association Between Treatment Patterns and Healthcare Utilization Healthcare Cost and Utilization Associated With Biologic Treatment Patterns Among Patients With Psoriatic Arthritis: Analyses From a Large US Claims Database
KMK Participants : Piao OW, Zheng JZ
Rheumatology and Therapy
Understanding Real-world Patient Profiles & Identifying Primary Product Benefactor Patient Characteristics and Indicators of Treatment Initiation with Repository Corticotropin Injection in Patients with Rheumatoid Arthritis: A Claims Database Analysis
KMK Participant : Fahim M
Real-World Treatment Patterns
Real-World Treatment Patterns among Patients with Mycosis Fungoides and Sézary Syndrome in the United States between 2018 and 2020
KMK Participant : Huanxue Z.
International Journal of MS Care
Impact of switching to fingolimod versus injectable disease-modifying therapy cycling on risk of multiple sclerosis-related relapses: A retrospective analysis
KMK Participants : Huanxue Zhou, Olivia Wenxian Piao
Journal of Managed Care Specialty Pharmacy
Healthcare Utilization and Cost Associated With Switching Biologics Within the First Year of Biologic Treatment Initiation Among Patients With Ankylosing Spondylitis
KMK Participants : Piao OW, Zheng JZ
Advances in Therapy
Annual Cost Burden by Level of Relapse Severity in Patients with Multiple Sclerosis
KMK Participants : Huanxue Zhou
Clinicoeconomics And Outcomes Research
Group-Based Trajectory Modeling To Assess Adherence To Biologics Among Patients With Psoriasis
KMK Participants : Huanxue Zhou
The Journal of Headache and Pain
Real-world Product Value Demonstration Impact of erenumab on acute medication usage and health care resource utilization among migraine patients: a US claims database study
KMK Participants :Shen Y, Zhou L
International Journal of MS Care
Utilization and Treatment Patterns of Disease-Modifying Therapy Among Pediatric Patients With Multiple Sclerosis in the United States
KMK Participants : Mengru Wang
JHEOR
Treatment patterns and health care costs in commercially insured patients with follicular lymphoma
KMK Participants : Chen G
Journal Of Managed Care & Specialty Pharmacy
Economic Impact Of Above-Label Dosing With Etanercept, Adalimumab, Or Ustekinumab In Patients With Psoriasis
KMK Participants : Huanxue Zhou
Looking for support along your commercialization journey? We'll help you make sense of your data.